Autres langues RAPT Therapeutics, Inc.

Actions

RAPT

US75382E1091

Temps réel estimé Cboe BZX Autres places de cotation 16:53:16 30/04/2024			Varia. 5j.	Varia. 1 janv.
7,81 ^USD	-0,89%		-3,25%	-68,85%

09/04	RAPT Therapeutics annonce des résultats prometteurs de l'essai de phase 2 de tivumecirnon en association avec l'immunothérapie anti-PD-1 chez des patients atteints de cancer de la tête et du cou ayant déjà reçu un IPC	CI
27/03	RAPT THERAPEUTICS, INC. : JPMorgan Chase maintient sa recommandation neutre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	09/04
RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P Biotechnology Select Industry Index	18/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT	11/03
RAPT Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	07/03
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	07/03
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting	05/03
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting	05/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT	03/03
RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	26/02
North American Morning Briefing : S&P 500 Futures -2-	23/02
RAPT Therapeutics Shares Decline Following UBS Downgrade	22/02
North American Morning Briefing : Nvidia Ignites -2-	22/02
North American Morning Briefing : Stock Futures -2-	21/02
Sector Update: Health Care Stocks Lower Late Afternoon	20/02
Top Midday Decliners	20/02
RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold	20/02
Two RAPT Therapeutics Studies Put on Hold by FDA After Adverse Event	20/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RAPT Therapeutics, Inc.

Actions

RAPT

US75382E1091

Autres langues

Filtres